Latest News
Calypso Medical Technologies, a developer of technology used for the precise tracking of tumour targets, has completed a USD50m round of venture capital financing, led by Skyline Ventures and Frazier Healthcare Ventures.
Bay City Capital and InterWest Partners were also major investors in the financing.
Proceeds from this financing will be used to support the company’s commercial expansion, both domestically and internationally, as well as the development of products to support new clinical indications and the continued integration of the Calypso System with existing linear accelerators and other radiation therapy technologies.
The company’s platform technology, also known as GPS for
Esbatech, a Swiss based unquoted portfolio company, has been acquired by Alcon to obtain Esbatech’s ophthalmic assets for USD150m upfront and USD439m in achievement based milestones.
International Biotechnology Trust currently has an investment in Esbattech of GBP1,039,545, invested since July 2006. The director’s have changed the valuation of IBT’s interest in Esbatech from GBP1.3m to GBP2.2m to reflect the terms of the deal.
The upfront payment is recognised in full at GBP1.9m, the escrow payments are recognised at 50 per cent of their value (GBP0.2m) and milestone payments due in the next 24 months make up GBP0.1m of the valuation.
Beacon E&P, an independent oil and natural gas company headquartered in Denver, Colorado, has received USD150m in equity commitments from Kayne Anderson Energy Funds, BAML Capital Partners, management and other investors.
Beacon was formed in June 2009 by Jim Lightner, Rod Mellott and Stu Wagner.
Lightner previously served as chairman, president and chief executive officer of Tom Brown, which was acquired by EnCana in 2004, and was a founding partner of Orion Energy Partners.
Mellott previously served as vice president of land and business development at Tom Brown and was a founding partner of Orion.
Wagner was a founding partner
For all those convinced that the culture of risk embodied in hedge funds was a prime cause of the financial and economic meltdown of the past two years, yesterday’s headlines provided more than a frisson of outrage: Barclays Bank has provided a group of 45 departing employees with some USD12.6bn to take a bundle of “toxic assets” off its hands through an investment vehicle in the Cayman Islands.
With up to USD450m in backing from two hedge funds, the former Barclays bankers have set up C12 Asset Management in New York, which in turn will manage the portfolio of assets
The International Brotherhood of Teamsters has written a letter to the co-chief executives of Kohlberg Kravis Roberts outlining their concerns over the private equity firm’s planned ini
Norwest Equity Partners, a private equity firm focused on middle market company investments, it has expanded its group of operating partners with the addition of Jim Lindner.
American Capital has completed the sale of its portfolio company Axygen BioScience, including its subsidiaries Axygen and Sorenson BioScience, to Corning for approximately USD400m.
Lloyds TSB Corporate Markets’ acquisition finance team in London has provided a GBP7.5m package of senior debt to support Sovereign Capital’s GBP18m acquisition of London Care and the b
Adobe Systems and Omniture have entered into a definitive agreement for Adobe to acquire Omniture in a transaction valued at approximately USD1.8bn on a fully diluted equity-value basis
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
